Myeong Ho Lee

Title: Myeong Ho Lee: Innovator in Electrochemical Biosensors

Introduction

Myeong Ho Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biosensors, particularly in improving the accuracy of blood glucose measurements. His innovative work has the potential to enhance diabetes management for patients worldwide.

Latest Patents

Myeong Ho Lee holds a patent for an "Electrochemical biosensor with improved accuracy." This invention focuses on an electrochemical biosensor designed to measure blood glucose levels with enhanced accuracy by correcting hematocrit values. The biosensor features a first electrode part that corrects the hematocrit measurement and a second electrode part that measures glucose concentration. The design includes a thinner insulation cover, ensuring equal exposure of the electrodes to the blood sample, which ultimately leads to more reliable glucose readings.

Career Highlights

Myeong Ho Lee is associated with I-Sens, Inc., a company dedicated to developing advanced medical devices. His work at I-Sens has positioned him as a key player in the field of medical technology, particularly in the development of biosensors that improve patient care.

Collaborations

Myeong Ho Lee has collaborated with notable colleagues, including Moon Hwan Kim and Ung Ki Lee. These partnerships have fostered innovation and contributed to the advancement of biosensor technology.

Conclusion

Myeong Ho Lee's contributions to the field of electrochemical biosensors exemplify the impact of innovative thinking in healthcare technology. His work not only enhances the accuracy of blood glucose measurements but also plays a crucial role in improving the quality of life for individuals managing diabetes.